Peptide Therapeutics Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide Therapeutics Drugs Market Perspective (2017-2028)
2.2 Peptide Therapeutics Drugs Growth Trends by Region
2.2.1 Peptide Therapeutics Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Peptide Therapeutics Drugs Historic Market Size by Region (2017-2022)
2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Region (2023-2028)
2.3 Peptide Therapeutics Drugs Market Dynamics
2.3.1 Peptide Therapeutics Drugs Industry Trends
2.3.2 Peptide Therapeutics Drugs Market Drivers
2.3.3 Peptide Therapeutics Drugs Market Challenges
2.3.4 Peptide Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Therapeutics Drugs Players by Revenue
3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2017-2022)
3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue
3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2021
3.5 Peptide Therapeutics Drugs Key Players Head office and Area Served
3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service
3.7 Date of Enter into Peptide Therapeutics Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Therapeutics Drugs Breakdown Data by Type
4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2017-2022)
4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2023-2028)
5 Peptide Therapeutics Drugs Breakdown Data by Application
5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2017-2022)
5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Peptide Therapeutics Drugs Market Size (2017-2028)
6.2 North America Peptide Therapeutics Drugs Market Size by Type
6.2.1 North America Peptide Therapeutics Drugs Market Size by Type (2017-2022)
6.2.2 North America Peptide Therapeutics Drugs Market Size by Type (2023-2028)
6.2.3 North America Peptide Therapeutics Drugs Market Share by Type (2017-2028)
6.3 North America Peptide Therapeutics Drugs Market Size by Application
6.3.1 North America Peptide Therapeutics Drugs Market Size by Application (2017-2022)
6.3.2 North America Peptide Therapeutics Drugs Market Size by Application (2023-2028)
6.3.3 North America Peptide Therapeutics Drugs Market Share by Application (2017-2028)
6.4 North America Peptide Therapeutics Drugs Market Size by Country
6.4.1 North America Peptide Therapeutics Drugs Market Size by Country (2017-2022)
6.4.2 North America Peptide Therapeutics Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peptide Therapeutics Drugs Market Size (2017-2028)
7.2 Europe Peptide Therapeutics Drugs Market Size by Type
7.2.1 Europe Peptide Therapeutics Drugs Market Size by Type (2017-2022)
7.2.2 Europe Peptide Therapeutics Drugs Market Size by Type (2023-2028)
7.2.3 Europe Peptide Therapeutics Drugs Market Share by Type (2017-2028)
7.3 Europe Peptide Therapeutics Drugs Market Size by Application
7.3.1 Europe Peptide Therapeutics Drugs Market Size by Application (2017-2022)
7.3.2 Europe Peptide Therapeutics Drugs Market Size by Application (2023-2028)
7.3.3 Europe Peptide Therapeutics Drugs Market Share by Application (2017-2028)
7.4 Europe Peptide Therapeutics Drugs Market Size by Country
7.4.1 Europe Peptide Therapeutics Drugs Market Size by Country (2017-2022)
7.4.2 Europe Peptide Therapeutics Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2017-2028)
8.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type
8.2.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Peptide Therapeutics Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application
8.3.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region
8.4.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide Therapeutics Drugs Market Size (2017-2028)
9.2 Latin America Peptide Therapeutics Drugs Market Size by Type
9.2.1 Latin America Peptide Therapeutics Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Peptide Therapeutics Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Peptide Therapeutics Drugs Market Share by Type (2017-2028)
9.3 Latin America Peptide Therapeutics Drugs Market Size by Application
9.3.1 Latin America Peptide Therapeutics Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Peptide Therapeutics Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Peptide Therapeutics Drugs Market Share by Application (2017-2028)
9.4 Latin America Peptide Therapeutics Drugs Market Size by Country
9.4.1 Latin America Peptide Therapeutics Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Peptide Therapeutics Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2017-2028)
10.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type
10.2.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Peptide Therapeutics Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application
10.3.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Peptide Therapeutics Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country
10.4.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction
11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.2.5 Eli Lilly Recent Developments
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.3.5 Novo Nordisk Recent Developments
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide Therapeutics Drugs Introduction
11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.4.5 Takeda Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Peptide Therapeutics Drugs Introduction
11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.5.5 Teva Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Peptide Therapeutics Drugs Introduction
11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.6.5 Novartis Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Ipsen
11.8.1 Ipsen Company Details
11.8.2 Ipsen Business Overview
11.8.3 Ipsen Peptide Therapeutics Drugs Introduction
11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.8.5 Ipsen Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Peptide Therapeutics Drugs Introduction
11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.9.5 AbbVie Recent Developments
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Peptide Therapeutics Drugs Introduction
11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.10.5 Allergan Recent Developments
11.11 Ferring
11.11.1 Ferring Company Details
11.11.2 Ferring Business Overview
11.11.3 Ferring Peptide Therapeutics Drugs Introduction
11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.11.5 Ferring Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Peptide Therapeutics Drugs Introduction
11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.12.5 Merck Recent Developments
11.13 JNJ
11.13.1 JNJ Company Details
11.13.2 JNJ Business Overview
11.13.3 JNJ Peptide Therapeutics Drugs Introduction
11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.13.5 JNJ Recent Developments
11.14 Tarix Pharmaceuticals
11.14.1 Tarix Pharmaceuticals Company Details
11.14.2 Tarix Pharmaceuticals Business Overview
11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction
11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.14.5 Tarix Pharmaceuticals Recent Developments
11.15 Lonza
11.15.1 Lonza Company Details
11.15.2 Lonza Business Overview
11.15.3 Lonza Peptide Therapeutics Drugs Introduction
11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2017-2022)
11.15.5 Lonza Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide Therapeutics Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Peptide Therapeutics Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Peptide Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Peptide Therapeutics Drugs Market Share by Region (2017-2022)
Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Peptide Therapeutics Drugs Market Share by Region (2023-2028)
Table 11. Peptide Therapeutics Drugs Market Trends
Table 12. Peptide Therapeutics Drugs Market Drivers
Table 13. Peptide Therapeutics Drugs Market Challenges
Table 14. Peptide Therapeutics Drugs Market Restraints
Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Peptide Therapeutics Drugs Revenue Share by Players (2017-2022)
Table 17. Global Top Peptide Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2021)
Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service
Table 22. Date of Enter into Peptide Therapeutics Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2017-2022)
Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2023-2028)
Table 28. Global Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Peptide Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Peptide Therapeutics Drugs Revenue Share by Application (2023-2028)
Table 32. North America Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Peptide Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Peptide Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Peptide Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Peptide Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Peptide Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Peptide Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Peptide Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Peptide Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Peptide Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Peptide Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Peptide Therapeutics Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Peptide Therapeutics Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Peptide Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Peptide Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Peptide Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Peptide Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Peptide Therapeutics Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Peptide Therapeutics Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Peptide Therapeutics Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Peptide Therapeutics Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Peptide Therapeutics Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Peptide Therapeutics Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Peptide Therapeutics Drugs Product
Table 65. Sanofi Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 66. Sanofi Recent Developments
Table 67. Eli Lilly Company Details
Table 68. Eli Lilly Business Overview
Table 69. Eli Lilly Peptide Therapeutics Drugs Product
Table 70. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 71. Eli Lilly Recent Developments
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Peptide Therapeutics Drugs Product
Table 75. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 76. Novo Nordisk Recent Developments
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Peptide Therapeutics Drugs Product
Table 80. Takeda Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 81. Takeda Recent Developments
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Peptide Therapeutics Drugs Product
Table 85. Teva Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 86. Teva Recent Developments
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Peptide Therapeutics Drugs Product
Table 90. Novartis Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 91. Novartis Recent Developments
Table 92. AstraZeneca Company Details
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Peptide Therapeutics Drugs Product
Table 95. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 96. AstraZeneca Recent Developments
Table 97. Ipsen Company Details
Table 98. Ipsen Business Overview
Table 99. Ipsen Peptide Therapeutics Drugs Product
Table 100. Ipsen Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 101. Ipsen Recent Developments
Table 102. AbbVie Company Details
Table 103. AbbVie Business Overview
Table 104. AbbVie Peptide Therapeutics Drugs Product
Table 105. AbbVie Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 106. AbbVie Recent Developments
Table 107. Allergan Company Details
Table 108. Allergan Business Overview
Table 109. Allergan Peptide Therapeutics Drugs Product
Table 110. Allergan Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 111. Allergan Recent Developments
Table 112. Ferring Company Details
Table 113. Ferring Business Overview
Table 114. Ferring Peptide Therapeutics Drugs Product
Table 115. Ferring Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 116. Ferring Recent Developments
Table 117. Merck Company Details
Table 118. Merck Business Overview
Table 119. Merck Peptide Therapeutics Drugs Product
Table 120. Merck Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 121. Merck Recent Developments
Table 122. JNJ Company Details
Table 123. JNJ Business Overview
Table 124. JNJ Peptide Therapeutics Drugs Product
Table 125. JNJ Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 126. JNJ Recent Developments
Table 127. Tarix Pharmaceuticals Company Details
Table 128. Tarix Pharmaceuticals Business Overview
Table 129. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product
Table 130. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 131. Tarix Pharmaceuticals Recent Developments
Table 132. Lonza Company Details
Table 133. Lonza Business Overview
Table 134. Lonza Peptide Therapeutics Drugs Product
Table 135. Lonza Revenue in Peptide Therapeutics Drugs Business (2017-2022) & (US$ Million)
Table 136. Lonza Recent Developments
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Therapeutics Drugs Market Share by Type: 2021 VS 2028
Figure 2. Injection Features
Figure 3. Oral Features
Figure 4. Other Features
Figure 5. Global Peptide Therapeutics Drugs Market Share by Application: 2021 VS 2028
Figure 6. Cancer Case Studies
Figure 7. Metabolic Disorders Case Studies
Figure 8. Central Nervous System Case Studies
Figure 9. Other Case Studies
Figure 10. Peptide Therapeutics Drugs Report Years Considered
Figure 11. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Peptide Therapeutics Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Peptide Therapeutics Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Peptide Therapeutics Drugs Market Share by Players in 2021
Figure 15. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2021
Figure 17. North America Peptide Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Peptide Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Peptide Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Peptide Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Peptide Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Peptide Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Peptide Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Peptide Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Peptide Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Peptide Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Peptide Therapeutics Drugs Market Size Share by Region (2017-2028)
Figure 37. China Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Peptide Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Peptide Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Peptide Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Peptide Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Peptide Therapeutics Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Peptide Therapeutics Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Peptide Therapeutics Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 57. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 58. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 59. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 60. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 61. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 62. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 63. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 64. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 65. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 66. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 67. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 68. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 69. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 70. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Industry Market Size
